Skip to main content

Table 1 The most differential predicted secretome of adipose and liver tissues

From: Comparative analysis of the human hepatic and adipose tissue transcriptomes during LPS-induced inflammation leads to the identification of differential biological pathways and candidate biomarkers

ACC.

NAME4

GENE

AT FC

AT p value

AT avg - LPS

AT avg + LPS

AT std - LPS

AT std + LPS

LT FC

LT p value

LT avg - LPS

LT avg + LPS

LT std - LPS

LT std + LPS

P01584

INTERLEUKIN 1, BETA

IL1B

20

1, 18E-06

584, 3

11733, 8

496, 8

3295, 7

100

0, 0002

9, 5

957, 6

17, 6

305, 3

P10147

CHEMOKINE (C-C MOTIF) LIGAND 3

CCL3

19.8

2, 0E-07

239, 3

4732, 6

160, 7

2239, 1

10.7

0, 0088

48, 7

521, 6

55, 4

226, 4

Q96DR8

SMALL BREAST EPITHELIAL MUCIN

MUCL1

17.4

5, 5E-05

36, 4

607, 9

20, 9

759, 2

5.8

0, 0008

5, 1

30, 0

2, 3

14, 8

P18510

INTERLEUKIN 1 RECEPTOR ANTAGONIST

IL1RN

12.5

9, 4E-06

16, 6

207, 4

6, 3

164, 7

6.5

0, 0148

118, 4

768, 3

127, 8

1132, 3

P78556

CHEMOKINE (C-C MOTIF) LIGAND 20

CCL20

11.4

7, 2E-06

1602, 6

18245, 7

1844, 3

2070, 8

7.5

0, 0199

1149, 2

8631, 9

306, 4

1263, 2

P16619

CHEMOKINE (C-C MOTIF) LIGAND 3-LIKE 1

CCL3L1

10.7

3, 4E-07

49, 7

1715, 4

38, 6

894, 1

34.5

0, 0088

48, 7

521, 6

55, 4

226, 4

P42830

CHEMOKINE (C-X-C MOTIF) LIGAND 5

CXCL5

7.8

1, 5E-04

735, 9

5489, 8

1215, 8

2385, 3

30.3

0, 0000

13, 9

330, 5

1, 9

23, 3

P35354

PROSTAGLANDIN-ENDOPEROXIDE SYNTHASE 2

PTGS2

6.8

5, 1E-05

1530, 5

10373, 9

1772, 5

2532, 4

7.9

0, 0478

39, 9

315, 1

3, 9

63, 5

P13501

CHEMOKINE (C-C MOTIF) LIGAND 5/RANTES

CCL5

6.3

1, 4E-06

252, 5

1588, 3

190, 4

458, 9

68

0, 0002

15, 8

1074, 0

17, 0

1425, 3

P05120

SERPIN PEPTIDASE INHIBITOR

SERPINB2

6

1, 1E-06

1825, 8

10909, 0

856, 7

2503, 1

8

0, 0022

25, 0

200, 7

37, 0

104, 9

P01583

INTERLEUKIN 1, ALPHA

IL1A

5.8

4, 4E-04

343, 2

1979, 4

211, 1

820, 6

4.3

0, 0043

7, 3

32, 1

2, 3

4, 2

O14625

CHEMOKINE (C-X-C MOTIF) LIGAND 11

CXCL11

5.4

1, 3E-03

19, 1

102, 5

15, 9

63, 2

20.4

0, 0269

10, 5

214, 6

17, 2

1379, 4

P05231

INTERLEUKIN 6 (INTERFERON, BETA 2)

IL6

4.5

2, 1E-05

4702, 1

21313, 8

3820, 2

1972, 7

17.8

0, 0097

40, 6

722, 6

52, 8

703, 0

P08254

MATRIX METALLOPEPTIDASE 3

MMP3

4

5, 5E-04

1333, 4

5331, 4

1458, 8

1982, 5

20.6

0, 0377

12, 2

251, 5

115, 5

725, 9

P09038

FIBROBLAST GROWTH FACTOR 2 (BASIC)

FGF2

3.7

7, 1E-04

173, 4

642, 5

165, 2

200, 0

3.5

0, 0020

13, 7

48, 4

5, 5

32, 0

P39900

MATRIX METALLOPEPTIDASE 12 (MACROPHAGE ELASTASE)

MMP12

3.7

1, 5E-04

22, 1

81, 7

8, 9

41, 1

5.8

0, 0220

19, 0

110, 8

31, 8

102, 9

P09341

CHEMOKINE (C-X-C MOTIF) LIGAND 1

CXCL1

3

1, 0E-03

4666, 1

14183, 2

5268, 4

3237, 7

23.5

0, 0013

70, 1

1648, 1

45, 5

615, 2

P02778

CHEMOKINE (C-X-C MOTIF) LIGAND 10

CXCL10

2.9

1, 4E-03

361, 5

1045, 7

248, 5

461, 4

17

0, 0431

72, 3

1234, 9

4543, 9

297, 8

P80162

CHEMOKINE (C-X-C MOTIF) LIGAND 6

CXCL6

2.8

1, 3E-03

2632, 1

7420, 4

2720, 0

1531, 1

22

0, 0033

20, 4

447, 3

49, 8

174, 3

P10144

GRANZYME B

GZMB

2.8

5, 1E-04

31, 8

87, 9

8, 5

38, 9

6.1

0, 0253

11, 9

73, 1

7, 6

91, 3

O60462

NEUROPILIN 2

NRP2

2.6

7, 0E-06

25, 0

65, 5

9, 0

7, 5

2.6

0, 0211

27, 9

72, 7

4, 8

15, 3

P10145

INTERLEUKIN 8

IL8

2.5

2, 1E-03

9738, 0

23999, 7

7532, 4

1532, 3

6

0, 0038

358, 9

4271, 3

480, 9

1244, 2

P13500

CHEMOKINE (C-C MOTIF) LIGAND 2

CCL2

2.3

5, 1E-06

5528, 4

12745, 4

1561, 6

1659, 7

3.7

0, 0435

726, 0

2675, 4

321, 4

366, 3

P16581

SELECTIN E (ENDOTHELIAL ADHESION MOLECULE 1)

SELE

105.1

1, 9E-06

5, 3

558, 7

4, 9

191, 7

4, 6

0, 6116

6, 9

31, 4

4, 7

31, 9

P04141

COLONY STIMULATING FACTOR 2

CSF2

82.5

1, 7E-07

9, 0

742, 5

12, 3

402, 4

1, 6

0, 4180

1, 6

2, 7

5, 2

2, 5

Q9BYE3

LATE CORNIFIED ENVELOPE 3D

LCE3D

46

1, 2E-05

-2, 7

70, 3

4, 1

103, 9

-1, 2

0, 7820

8, 2

7, 0

5, 1

6, 7

P02763

OROSOMUCOID 1

ORM1

26.6

2, 3E-03

12, 4

329, 5

8, 8

470, 6

1, 0

0, 7173

4506, 7

4609, 2

1108, 8

582, 4

O14944

EPIREGULIN

EREG

25

1, 8E-06

-3, 1

17, 1

4, 0

8, 7

-2, 0

0, 8984

2, 8

1, 3

2, 0

4, 5

P22894

MATRIX METALLOPEPTIDASE 8 (NEUTROPHIL COLLAGENASE)

MMP8

22.2

1, 3E-03

2, 3

51, 3

5, 7

48, 1

1, 5

0, 4560

10, 6

15, 9

9, 7

18, 5

Q00604

NORRIE DISEASE (PSEUDOGLIOMA)

NDP

19.5

3, 8E-07

15, 1

295, 4

13, 4

165, 2

1, 3

0, 9185

1, 5

1, 9

1, 6

2, 5

P07357

COMPLEMENT COMPONENT 8, ALPHA POLYPEPTIDE

C8A

18.6

3, 6E-04

18, 6

345, 7

21, 4

179, 7

-1, 6

0, 5130

780, 6

481, 8

421, 3

165, 0

P78423

FRACTALCINE

CX3CL1

6.4

5, 6E-07

97, 1

617, 8

29, 9

285, 0

9.9

0, 6235

23.4

232.5

14.3

431.9

P01375

TUMOR NECROSIS FACTOR (TNF SUPERFAMILY, MEMBER 2)

TNF

6

3, 5E-10

28, 8

173, 4

5, 5

30, 3

1, 6

0, 9980

7, 8

12, 8

4, 4

7, 5

Q9UHD0

INTERLEUKIN 19

IL19

5.6

9, 7E-06

6, 2

34, 9

3, 0

13, 1

1, 8

0, 5200

-2, 0

-3, 4

3, 0

4, 8

P26022

PENTRAXIN-RELATED GENE, RAPIDLY INDUCED BY IL-1 BETA

PTX3

4

1, 0E-04

992, 2

4000, 0

614, 4

1504, 4

2, 1

0, 6562

7, 5

15, 5

7, 2

7, 8

P03956

MATRIX METALLOPEPTIDASE 1 (INTERSTITIAL COLLAGENASE)

MMP1

3.4

3, 0E-04

2662, 1

8995, 1

3099, 1

1471, 0

1, 0

0, 5981

928, 4

968, 5

1473, 1

441, 9

Q9BY76

ANGIOPOIETIN-LIKE 4

ANGPTL4

3.2

2, 9E-03

83, 8

268, 7

45, 7

139, 2

2, 0

0, 5980

70, 6

137, 9

34, 0

156, 1

P19875

CHEMOKINE (C-X-C MOTIF) LIGAND 2

CXCL2

3.1

7, 3E-04

1753, 9

5471, 3

1121, 4

1569, 5

1, 4

0, 4725

13, 7

19, 1

5, 3

5, 8

P05121

SERPIN PEPTIDASE INHIBITOR/PLASMINOGEN ACTIVATOR INHIBITOR TYPE 1) MEMBER 1

SERPINE1/

pai1

3

6, 1E-04

3110, 0

9426, 1

2165, 8

2364, 8

1, 7

0, 7450

64, 6

108, 5

29, 1

81, 8

P10124

PROTEOGLYCAN 1, SECRETORY GRANULE

SRGN

2.7

3, 2E-05

3141, 4

8426, 4

1107, 6

2008, 1

1, 1

1, 0000

3, 4

3, 6

3, 0

1, 5

Q96RQ9

INTERLEUKIN 4 INDUCED 1

IL4I1

2.4

2, 4E-03

132, 4

318, 9

73, 6

149, 7

-1, 6

0, 7500

-1, 2

-0, 8

3, 5

5, 1

Q9Y5U4

INSULIN INDUCED GENE 2

INSIG2

2.3

8, 5E-04

316, 7

722, 0

129, 6

225, 9

-1, 2

0, 8880

94, 3

79, 9

38, 4

11, 1

P12643

BONE MORPHOGENETIC PROTEIN 2

BMP2

2.2

3, 4E-04

1131, 3

2465, 7

472, 0

655, 5

1, 7

0, 6915

91, 6

158, 3

103, 2

87, 3

P02735

SERUM AMYLOID A1

SAA1

2.2

2, 2E-03

355, 1

778, 1

165, 9

246, 5

1, 1

0, 9120

4896, 1

5144, 0

564, 6

238, 5

Q07325

CHEMOKINE (C-X-C MOTIF) LIGAND 9

CXCL9

1.8

5, 5E-02

207, 1

376, 4

231, 9

233, 9

69.3

0, 0009

33, 0

2288, 5

66, 7

3090, 5

P19876

CHEMOKINE (C-X-C MOTIF) LIGAND 3

CXCL3

3.6

9, 6E-03

15, 5

56, 0

7, 9

29, 7

20.6

0, 0050

28, 1

587, 5

8, 9

300, 0

O95633

FOLLISTATIN-LIKE 3 (SECRETED GLYCOPROTEIN)

FSTL3

1

9, 3E-01

687, 0

665, 4

224, 2

136, 2

15.1

0, 0036

32, 8

495, 5

86, 8

378, 1

Q13113

PDZK1 INTERACTING PROTEIN 1

PDZK1IP1

1.9

2, 3E-01

43, 0

84, 2

25, 9

54, 7

12.9

0, 0010

13, 0

169, 4

51, 6

168, 3

Q9NRD8

DUAL OXIDASE 2

DUOX2

-2

3, 5E-01

4, 9

2, 3

2, 9

3, 8

5.5

0, 0084

77, 2

428, 5

49, 2

154, 2

Q8WWX9

SELENOPROTEIN M

SELM

1.6

5, 2E-03

2336, 5

3877, 9

840, 8

945, 4

3.9

0, 0025

114, 1

445, 5

37, 0

79, 2

O94808

GLUTAMINE-FRUCTOSE-6-PHOSPHATE TRANSAMINASE 2

GFPT2

1.7

1, 3E-04

2797, 3

4808, 3

419, 1

945, 3

3.6

0, 0019

15, 1

54, 6

3, 3

2, 7

P13164

INTERFERON INDUCED TRANSMEMBRANE PROTEIN 1 (9-27)

IFITM1

- 1.1

7, 3E-01

2134, 1

1986, 2

785, 1

682, 9

3.5

0, 0435

375, 2

1318, 2

462, 2

466, 0

P09603

COLONY STIMULATING FACTOR 1 (MACROPHAGE)

CSF1

- 1.6

3, 0E-02

128, 4

73, 4

53, 5

28, 0

3.3

0, 0056

73, 4

242, 7

19, 3

118, 7

P12544

GRANZYME A

GZMA

- 1.4

2, 2E-01

123, 1

85, 7

55, 7

25, 5

3.3

0, 0215

6, 7

21, 9

3, 6

27, 1

P25774

CATHEPSIN S

CTSS

1.4

1, 2E-02

135, 5

194, 8

43, 5

31, 0

3.2

0, 0168

270, 5

881, 9

86, 8

355, 9

P24001

INTERLEUKIN 32

IL32

1.6

5, 0E-06

551, 7

888, 2

42, 1

121, 3

3

0, 0061

2723, 6

8331, 0

668, 1

472, 2

P31431

SYNDECAN 4 (AMPHIGLYCAN, RYUDOCAN)

SDC4

1.9

1, 5E-02

1049, 2

1962, 3

453, 7

796, 4

2.7

0, 0111

1141, 2

3088, 8

160, 0

643, 0

P03973

SECRETORY LEUKOCYTE PEPTIDASE INHIBITOR

SLPI

- 1.4

1, 0E+00

1063, 8

755, 9

946, 2

387, 2

2.7

0, 0050

1505, 1

4153, 1

255, 9

660, 6

P09237

MATRIX METALLOPEPTIDASE 7 (MATRILYSIN, UTERINE)

MMP7

- 1.6

4, 2E-01

7, 9

4, 5

13, 2

15, 1

2.6

0, 0244

8, 7

22, 8

12, 3

34, 0

Q5VY09

IMMEDIATE EARLY RESPONSE 5

IER5

1.6

4, 7E-03

471, 5

780, 8

99, 5

258, 3

2.5

0, 0215

139, 5

347, 3

79, 7

90, 2

O75976

CARBOXYPEPTIDASE D

CPD

1.3

1, 2E-01

761, 1

1012, 4

282, 7

315, 0

2.2

0, 0335

54, 8

118, 9

47, 3

51, 3

  1. Fold change (FC) for the highest and significantly upregulated genes (p ≤ 0.05) upon LPS treatment (+LPS) compared to control (-LPS) in adipose tissue (AT), n = 7 and liver tissue (LT) n = 5 are indicated in bold and are underlined. FCs for not significantly changed genes in both tissues (p > 0.05) are in italics. Additionally, information about average (avg) gene expression value and it's standard deviation (std) for both AT and LT is given.